Your browser doesn't support javascript.
loading
C5a elevation in convalescents from severe COVID-19 is not associated with early complement activation markers C3bBbP or C4d.
Kowalska, Daria; Kuzniewska, Alicja; Senent, Yaiza; Tavira, Beatriz; Inogés, Susana; López-Díaz de Cerio, Ascensión; Pio, Ruben; Okrój, Marcin; Yuste, José Ramón.
Afiliación
  • Kowalska D; Department of Cell Biology and Immunology, Intercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, Gdansk, Poland.
  • Kuzniewska A; Department of Cell Biology and Immunology, Intercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, Gdansk, Poland.
  • Senent Y; Program in Solid Tumors, Translational Oncology Group, Cima-University of Navarra and Cancer Center University of Navarra (CCUN), Pamplona, Spain.
  • Tavira B; Department of Biochemistry and Genetics, School of Sciences, University of Navarra, Pamplona, Spain.
  • Inogés S; Department of Oncology and Hematology, Navarra Institute for Health Research (IdISNA), Pamplona, Spain.
  • López-Díaz de Cerio A; Program in Solid Tumors, Translational Oncology Group, Cima-University of Navarra and Cancer Center University of Navarra (CCUN), Pamplona, Spain.
  • Pio R; Department of Biochemistry and Genetics, School of Sciences, University of Navarra, Pamplona, Spain.
  • Okrój M; Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, Pamplona, Spain.
  • Yuste JR; Department of Oncology and Hematology, Navarra Institute for Health Research (IdISNA), Pamplona, Spain.
Front Immunol ; 13: 946522, 2022.
Article en En | MEDLINE | ID: mdl-36091057

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fragmentos de Péptidos / Complemento C3b / Factor B del Complemento / Complemento C4b / Complemento C5a / Activación de Complemento / COVID-19 Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Polonia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fragmentos de Péptidos / Complemento C3b / Factor B del Complemento / Complemento C4b / Complemento C5a / Activación de Complemento / COVID-19 Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Polonia